KyDo Therapeutics
PrivateLast Round
Seed
Sep 16, 2025
Total Funding Raised
$5.28M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
KyDo Therapeutics is a biotechnology company that develops novel covalent-allosteric small molecule inhibitors with the potential to become first-in-class oncology drugs.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
KyDo Therapeutics Comparables
Compare KyDo Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nexo Therapeutics | 81% | |
| Matchpoint Therapeutics | 79% | |
| Allorion Therapeutics | 77% | |
KyDo Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Sep 16, 2025 |
KyDo Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| TU capital | Seed |
| KHAN Technology Transfer Fund II | Seed |
| VORNvc | Seed |
| i&i Prague | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 16, 2025
$5.28M round led by i&i Biotech Fund I
KyDo Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about KyDo Therapeutics's valuation, stock price, and market status.